Necrotic Enteritis in Poultry: Etiology, Pathogenesis, Diagnosis, and Control
What is Necrotic Enteritis
Necrotic enteritis (NE) is an acute, often fatal enteric disease of poultry, primarily affecting broiler chickens, caused by the anaerobic, spore-forming bacterium Clostridium perfringens [1, 2, 3]. The disease is characterized by severe, focal to diffuse necrosis of the intestinal mucosa, leading to significant economic losses in the poultry industry due to increased mortality, reduced growth performance, and increased feed conversion ratios [4, 5, 6]. Understanding what is necrotic enteritis requires a detailed examination of its multifactorial etiology, complex pathogenesis, and the interplay between host, pathogen, and environmental factors [3, 7, 8].
Etiology
The primary etiological agent of NE is Clostridium perfringens, a Gram-positive, rod-shaped, anaerobic bacterium capable of producing a wide array of extracellular toxins [9, 3, 10]. While C. perfringens is a normal inhabitant of the intestinal microbiota of healthy poultry at low levels, specific predisposing factors allow for its massive proliferation and the subsequent expression of key virulence factors [1, 7, 11].
Toxinotypes and Virulence Factors
C. perfringens is classified into toxinotypes (A through G) based on the production of major toxins (alpha, beta, epsilon, iota, and NetB) [9, 3]. For decades, NE was primarily associated with type A strains producing alpha-toxin (CPA). However, the discovery of the NetB toxin (Necrotic Enteritis B-like toxin) was a pivotal advancement [10]. NetB is a pore-forming toxin that is now considered the primary virulence factor for NE in poultry, leading to the classification of NE-associated strains as type G [9, 3, 10]. The NetB toxin causes the formation of pores in the plasma membrane of host enterocytes, leading to osmotic lysis and cell death, which is the direct cause of the characteristic mucosal necrosis [3, 10].
Other virulence factors contribute to the pathogenesis. Alpha-toxin, a phospholipase C, possesses hemolytic and necrotic activities and may act synergistically with NetB [3, 12]. Additionally, C. perfringens produces a range of enzymes, including collagenase, hyaluronidase, and sialidase, which facilitate tissue degradation and bacterial spread within the intestinal lamina propria [3]. The ability to form biofilms is another important trait, enhancing bacterial survival and persistence in the environment and within the host [12].
Predisposing Factors
The transition of C. perfringens from a commensal organism to a pathogen is dependent on specific predisposing factors that disrupt the normal intestinal ecosystem [3, 8].
Coccidiosis: Infection with Eimeria species is the most significant predisposing factor for NE [3, 8]. Coccidial replication within enterocytes causes mucosal damage, leading to the leakage of plasma proteins and nutrients into the intestinal lumen. This protein-rich environment provides an ideal substrate for the rapid proliferation of C. perfringens [3, 8].
Diet: Dietary composition plays a critical role. High levels of crude protein, particularly those containing high amounts of indigestible proteins (e.g., fishmeal, soybean meal), increase the availability of substrates for C. perfringens in the distal ileum [5, 11]. Diets based on barley or wheat, which are high in non-starch polysaccharides (NSPs), increase digesta viscosity, slowing transit time and promoting bacterial overgrowth [11].
Immunosuppression: Factors that compromise the immune system, such as infectious bursal disease virus or mycotoxin contamination of feed, can increase susceptibility to NE [3].
Epidemiology
NE occurs worldwide and is considered one of the most economically important bacterial diseases of poultry [1, 13]. The disease is most commonly seen in broiler chickens between 2 and 6 weeks of age, although it can also affect layers and turkeys [2, 7]. The incidence of NE has increased significantly following the global trend of reducing or banning the use of in-feed antibiotic growth promoters (AGPs), which previously provided effective prophylaxis [13, 8].
The epidemiology of NE is closely linked to the presence of C. perfringens spores in the environment [7]. Spores are highly resistant and can persist in poultry houses, litter, feed, and water, serving as a continuous source of infection for subsequent flocks [7]. Molecular epidemiological studies using pulsed-field gel electrophoresis (PFGE) and rpoB sequence typing have revealed a high degree of genetic diversity among C. perfringens isolates from different farms and regions, although certain clones may be more frequently associated with disease [2, 14]. The spore load in the environment has been correlated with the occurrence of NE outbreaks on farms [7].
Pathogenesis
The pathogenesis of NE is a sequential, multifactorial process. The initial step involves the disruption of the intestinal mucosal barrier, most commonly by Eimeria spp. [3, 8]. This damage exposes the underlying connective tissue and provides a rich source of amino acids and peptides for C. perfringens [3]. Concurrently, dietary factors such as high NSP levels increase digesta viscosity, creating a favorable environment for anaerobic bacterial growth [11].
As C. perfringens populations expand, they upregulate the production of virulence factors, most critically the NetB toxin [10]. NetB inserts into the enterocyte membrane, forming heptameric pores that disrupt ion gradients, leading to cell swelling and oncotic necrosis [3]. The combined action of NetB, CPA, and other degradative enzymes results in the characteristic coagulative necrosis of the villi and the formation of a diphtheritic membrane composed of fibrin, necrotic cells, and bacteria [3, 10]. The loss of absorptive surface area and the systemic effects of absorbed toxins lead to the clinical signs of the disease.
Clinical Signs
NE can present in two main forms: clinical and subclinical.
Clinical Necrotic Enteritis: This acute form is characterized by a sudden increase in flock mortality, often without premonitory signs [1, 3]. Affected birds appear depressed, huddle together, and exhibit ruffled feathers. Diarrhea is common, often described as dark, tarry, or mucoid [3]. Morbidity and mortality can be high, with mortality rates reaching 10-50% in untreated flocks [1, 3].
Subclinical Necrotic Enteritis: This form is more insidious and economically damaging. Birds do not show overt clinical signs but suffer from chronic damage to the intestinal mucosa [15, 16]. This results in poor nutrient absorption, leading to reduced weight gain, increased feed conversion ratio, and flock unevenness [5, 6, 16]. Subclinical NE is often undiagnosed but contributes significantly to production losses.
Pathology
Gross pathological lesions are primarily confined to the small intestine, particularly the jejunum and ileum [3, 10]. The intestinal wall is typically thin, friable, and distended with gas and fluid. The hallmark lesion is the presence of a characteristic "Turkish towel" appearance, where the mucosa is covered by a yellow-brown, necrotic, diphtheritic membrane [3, 10]. This membrane is often loosely attached and can be easily removed, revealing a hemorrhagic and ulcerated mucosal surface.
Microscopically, the lesions are characterized by severe coagulative necrosis of the villi, with massive infiltration of heterophils and fibrin [3]. Large numbers of Gram-positive rod-shaped bacteria are often visible within the necrotic debris and adhering to the mucosal surface [10].
Diagnosis
A definitive diagnosis of NE is based on a combination of clinical signs, gross pathology, histopathology, and laboratory confirmation of C. perfringens and its toxins [3, 10].
Necropsy and Histopathology
The presence of the characteristic gross lesions in the small intestine is highly suggestive of NE [3, 10]. Histopathological examination of affected intestinal sections confirms the diagnosis by demonstrating coagulative necrosis, fibrin deposition, and the presence of Gram-positive rods [3].
Microbiological Culture and Isolation
C. perfringens can be isolated from intestinal scrapings or liver samples by anaerobic culture on selective media (e.g., Tryptose Sulfite Cycloserine agar) [17, 10]. However, isolation alone is not diagnostic, as C. perfringens is a normal inhabitant of the gut. Quantification of C. perfringens levels (e.g., >10^6 CFU/g of intestinal content) can support a diagnosis of NE [1, 7].
Toxin Detection and Genotyping
Detection of the NetB toxin gene by polymerase chain reaction (PCR) is the gold standard for confirming the presence of pathogenic type G strains [9, 10]. PCR can be performed directly on intestinal contents or on cultured isolates. Toxinotyping can also be performed using multiplex PCR to differentiate between toxinotypes [9, 10]. Sequencing of the NetB gene can provide further epidemiological information [10].
Molecular Epidemiology
Advanced molecular typing methods, such as PFGE and rpoB sequence typing, are used for epidemiological investigations to track the spread of specific C. perfringens clones within and between flocks [2, 14].
Biomarkers
Recent research has explored the use of fecal acute-phase proteins as non-invasive biomarkers for monitoring NE in broiler flocks [18].
The following decision tree summarizes the diagnostic approach for NE.
graph TD
A[Suspicion of Necrotic Enteritis], > B{Clinical Signs & Mortality?};
B, Yes, > C[Perform Necropsy];
B, No, > D[Monitor for Subclinical Signs];
C, > E{Gross Lesions in Jejunum/Ileum?};
E, Yes (Turkish towel appearance), > F[Collect Intestinal Scrapings & Liver];
E, No, > G[Consider Other Enteric Diseases];
F, > H[Anaerobic Culture & Gram Stain];
H, > I[Quantify C. perfringens];
I, > J[PCR for NetB & Toxin Genes];
J, > K[Histopathology];
K, > L[Confirm NE Diagnosis];
D, > M[Assess Performance Data (FCR, BW)];
M, > N[Fecal Sampling for Biomarkers & PCR];
N, > O[Subclinical NE Diagnosis];
Treatment
Treatment of clinical NE is challenging due to the rapid course of the disease. Historically, in-feed antibiotics such as bacitracin methylene disalicylate, virginiamycin, and lincomycin were used for treatment and prevention [13]. However, with the global push to reduce antimicrobial use, alternative strategies are being developed and implemented [13, 19].
Antimicrobial Therapy
In regions where it is still permitted, water-soluble antibiotics (e.g., amoxicillin, tylosin) can be administered to treat acute outbreaks [3, 20]. However, antimicrobial susceptibility testing (AST) is critical to guide therapy, as resistance to commonly used antibiotics is increasing [17, 20]. The agar dilution and broth microdilution methods are standard techniques for AST of C. perfringens [17].
Alternative Therapeutic Strategies
A wide range of alternatives to conventional antibiotics are under investigation.
Probiotics and Direct-Fed Microbials: Bacillus species (e.g., B. subtilis, B. velezensis) and Enterococcus faecium have shown efficacy in reducing C. perfringens colonization and NE severity by competing for nutrients, producing antimicrobial metabolites, and modulating the gut microbiota [21, 22, 23, 24]. Lactobacillus species and their postbiotics also improve intestinal health and growth performance in NE-challenged birds [15, 25].
Bacteriophages: Lytic bacteriophages specific to C. perfringens offer a targeted approach to reduce pathogen load. Phage cocktails designed to overcome cross-resistance have shown promise in mitigating NE [26, 9, 27].
Organic Acids and Phytogenics: Dietary supplementation with organic acids (e.g., benzoic acid, butyric acid) and phytogenic feed additives (e.g., cinnamon essential oil, thymol, Balanites aegyptiaca extracts) can improve gut health, reduce C. perfringens counts, and attenuate NE-associated damage [4, 28, 6, 12, 19]. Glycerol monolaurate has also been shown to attenuate NE by improving gut-liver health [29].
Nanoparticles: Chitosan nanoparticles have demonstrated in vivo antibacterial activity against C. perfringens-induced NE [30].
Control
Effective control of NE requires an integrated approach that addresses the multifactorial nature of the disease [3, 13].
Management and Biosecurity
Strict biosecurity measures are essential to minimize the introduction and spread of C. perfringens spores [7]. This includes thorough cleaning and disinfection of poultry houses between flocks, with a focus on removing organic matter that can protect spores [7]. Litter management is critical; wet litter promotes coccidiosis and C. perfringens proliferation [3, 8].
Nutritional Strategies
Dietary manipulation is a cornerstone of NE control. Formulating diets with lower crude protein levels and optimized amino acid ratios reduces the substrate available for C. perfringens in the gut [5]. Supplementation with exogenous enzymes (e.g., xylanase) reduces digesta viscosity in wheat- or barley-based diets, thereby limiting bacterial overgrowth [11, 16].
Coccidiosis Control
Effective control of coccidiosis is paramount for preventing NE [3, 8]. This can be achieved through the use of anticoccidial drugs (ionophores or chemicals) or vaccination with live Eimeria vaccines [8]. The phase-out of ionophores in some regions has been linked to an increased incidence of NE, highlighting the importance of integrated coccidiosis management [8].
Vaccination
Considerable research is focused on developing effective vaccines against NE. Strategies include the use of recombinant NetB and other non-toxin antigens (e.g., FimB, CnaA, FBA) delivered via live vectors such as attenuated Salmonella or Lactobacillus [31, 32, 33, 34]. Multi-epitope vaccines designed using pangenome-based strategies are also being explored [31]. Oral immunization with these vectors aims to induce a protective mucosal immune response against C. perfringens [32, 33, 34].
Microbiome Modulation
Modulating the gut microbiota through the use of probiotics, prebiotics, and specific bacterial strains (e.g., Bacteroides thetaiotaomicron) is a promising strategy to enhance colonization resistance against C. perfringens [1, 21, 35, 15]. These approaches aim to restore a healthy microbial ecosystem that is less permissive to pathogen overgrowth.
References
[1] Cagirgan OY, Korkmaz S, Diker KS. Intestinal microbiome in necrotic enteritis infection of broiler and comparison of treatment alternatives. Trop Anim Health Prod. 2026.
[2] Karagulle B, Yerlikaya Z, Muz A. Molecular epidemiology and PFGE-based genetic diversity of Clostridium perfringens in broiler chickens from Eastern Türkiye. BMC Vet Res. 2026.
[3] Chen J, Ma T, Yang S et al. [Research progress in the pathogenic mechanisms and prevention and control of Clostridium perfringens]. Sheng Wu Gong Cheng Xue Bao. 2026.
[4] Long MH, Zhao X, Hu Z et al. Effects of dietary benzoic acid combined with cinnamon essential oil on growth performance, antioxidant capacity, immune function, and gut health in broiler, chickens with necrotic enteritis. Poult Sci. 2026.
[5] Asiamah CA, Musigwa S, Kheravii SK et al. Optimized amino acid ratios in reduced crude protein diets sustain broiler performance, gut health, and resilience to necrotic enteritis. Anim Nutr. 2026.
[6] Khairunnesa M, Kumar A, Wu SB et al. Phytogenic feed additive mitigates necrotic enteritis-associated gut damage and performance loss in broilers. Poult Sci. 2026.
[7] Kinstler SR, Lee MD, Wong EA et al. Correlation Between Avian Pathogenic Clostridium perfringens Spore Load and Occurrence of Necrotic Enteritis on Broiler Chicken Farms. Avian Dis. 2026.
[8] Estensmo EL, Granstad S, Stevens KB et al. A new era of coccidiosis control: Eimeria and Clostridium perfringens dynamics in vaccinated broiler flocks after the ionophore phase-out in Norway. Prev Vet Med. 2026.
[9] Duc HM, Lan NT, Hoa TTK et al. Toxinotyping, Antibiotic Resistance Profile, and In Vitro Bio-Control of Clostridium perfringens Type G Isolated from Chickens with Necrotic Enteritis by Lytic Bacteriophages. Antibiotics (Basel). 2026.
[10] Ahmed DAA, Hassan AK, Ali DAA et al. Molecular detection and sequencing of the NetB toxin Gene of clostridium perfringens and evaluation of its pathogenicity in broiler chicken. Poult Sci. 2026.
[11] Estensmo EL, Sekse C, Steinhoff FS et al. Cecal microbiota and Clostridium perfringens in broilers fed barley-based diets: Effects of enzyme supplementation and degree of grinding. Poult Sci. 2026.
[12] Bhattrai S, Sun Z, Jenkins M et al. Biofilm formation by clinical Clostridium perfringens isolates and its suppression by thymol. Poult Sci. 2026.
[13] Agunos A, Gow S, Reid-Smith R. Trends in Necrotic Enteritis and Coccidiosis Control Practices in Canadian Poultry Flocks, 2018-2023. Avian Dis. 2025.
[14] Ahn SM, Son S, Son Y et al. An rpoB Sequence Type Network as a Framework for the Evolutionary Investigation of Clostridium perfringens. Microorganisms. 2025.
[15] Hall AN, Manuja S, Payling LM et al. Lactobacillus-vectored nanobodies improve broiler productivity under sub-clinical necrotic enteritis with associated microbiome and transcriptome changes. NPJ Biofilms Microbiomes. 2026.
[16] Khairunnesa M, Kumar A, Wu SB et al. Xylanase and Bacillus subtilis PB6 modulate microbiota and short-chain fatty acid profiles in broilers under necrotic enteritis-challenge. Poult Sci. 2026.
[17] Charlebois A, Maduro L, Boulianne M. Comparison of antimicrobial susceptibility testing of Clostridium perfringens by agar dilution and broth microdilution methods. J Vet Diagn Invest. 2026.
[18] Mahmoud MA, Buiatte V, Baumrucker CR et al. Investigating Acute-Phase Proteins in Feces of Broiler Chickens Undergoing Necrotic Enteritis: A Potential Tool for Assessment and Monitoring. Avian Dis. 2026.
[19] Hamed RI, Nabil NM, Tawakol MM et al. The effective role of organic acids as antibiotic alternatives in controlling necrotic enteritis in broiler chickens. Poult Sci. 2026.
[20] Reedman C, Charlebois A, Hill S et al. Assessing the associations between antimicrobial use and antimicrobial susceptibility testing results in Clostridium perfringens in Canadian broiler chickens, turkeys, and layer chickens from 2018 to 2023. Anaerobe. 2026.
[21] Peng M, Ma G, Shi W et al. Dietary supplementation with Bacillus velezensis enhances the intestinal health of broiler chickens challenged with necrotic enteritis via reshaping the structure and function of the intestinal flora. Poult Sci. 2026.
[22] Mostafa AEA, Ramadan R, Sittien A. Probiotic Enterococcus faecium (M74) as an alternative to antibiotics for controlling necrotic enteritis in broiler chickens. Sci Rep. 2026.
[23] Dai Q, Ni J, Lu J et al. Probiotic characterization of Bacillus subtilis Strain BS-Q and its cell-free-supernatant-mediated inhibition of Clostridium perfringens. Lett Appl Microbiol. 2026.
[24] Wang Z, Zhang W, Dong Z et al. Optimization of culture conditions for enhanced antibacterial metabolite production by Bacillus velezensis TL and evaluation of its efficacy against necrotic enteritis in broilers. Poult Sci. 2026.
[25] Wu M, Zha Y, Xiong Y et al. Lactobacillus reuteri postbiotics improved growth performance and intestinal health of broilers with necrotic enteritis. BMC Vet Res. 2025. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.
[26] Manjunaha V, Justice-Alucho CH, Lumpkins BS et al. Combined effect of black cumin seeds and bacteriophage in mitigating necrotic enteritis in broiler chickens. J Appl Microbiol. 2026.
[27] Ahn E, Kim J, Tobin I et al. Cross-resistance-guided phage cocktail design for effective mitigation of necrotic enteritis in poultry. Microbiol Res. 2026.
[28] Ezzat A, Salem HM, Mahmoud SH et al. Comprehensive evaluation of Balanites aegyptiaca extracts: in vitro bioactivities and in vivo antimicrobial efficacy and hematological impact on broiler chickens challenged with E. coli O78 and Clostridium perfringens type A. Vet Res Commun. 2026.
[29] Kong L, Zhang X, Pan X et al. Glycerol monolaurate attenuates necrotic enteritis in broilers by improving gut-liver health and remodeling the gut microbiota. J Anim Sci Biotechnol. 2026.
[30] Elnagar R, Al-Khalidi AAH, Elkenany R et al. In vivo antibacterial activity of chitosan nanoparticles against Clostridium perfringens-induced necrotic enteritis in broilers. Ir Vet J. 2026.
[31] Greco JPG, Gonçalves CN, Conceição FR et al. A pangenome-based strategy for designing a multi-epitope vaccine against non-toxin antigens of necrotic enteritis-associated Clostridium perfringens. Braz J Microbiol. 2026.
[32] Li W, Li YA, Liu X et al. Oral immunization with attenuated Salmonella enterica serovar Enteritidis expressing dual-toxin antigen induces protective immunity against avian necrotic enteritis. Vaccine. 2026.
[33] Li W, Li YA, Liu X et al. Recombinant Attenuated Salmonella Enteritidis Vector Enhances the Immunogenicity of Clostridium perfringens EntB Antigen for Effective Prevention of Avian Necrotic Enteritis. Biomolecules. 2026.
[34] Yang T, Wang T, Zhang G et al. Oral administration of recombinant Lactobacillus plantarum co expressing FimB, CnaA, NetB and FBA antigens targeting chicken dendritic cells provides effective protection against necrotizing enteritis in broilers. Poult Sci. 2026.
[35] Alizadeh M, Oladokun S, Fazel F et al. Modulation of gut immunity and microbiota by Bacteroides thetaiotaomicron confers dose-dependent protection against necrotic enteritis in broiler chickens. Poult Sci. 2026.